← Back to Search

Behavioral Intervention

PD Participant with Cognitive Dysfunction for Parkinson's Disease (HOBSCOTCH-PD Trial)

N/A

Recruiting

Led By Elaine T Kiriakopoulos, MD, MPH, MSc

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of Parkinson's Disease per participant's provider

Literate, English-speaking with grade 12 or equivalent in education

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later.

Awards & highlights

HOBSCOTCH-PD Trial Summary

This trial aims to see if a home-based self-management program for epilepsy, called HOBSCOTCH, can be adapted for people with Parkinson's Disease. Participants will attend virtual sessions with a coach

Who is the study for?

This trial is for people with Parkinson's Disease who are experiencing cognitive impairment or memory loss. Participants will engage in a program called HOBSCOTCH-PD, which involves nine one-hour virtual sessions aimed at improving self-management and quality of life.Check my eligibility

What is being tested?

The study tests whether the HOBSCOTCH program, originally designed for epilepsy patients, can be adapted to help those with Parkinson's Disease. It measures if participants see an improvement in their quality of life and cognitive functions after completing the program.See study design

What are the potential side effects?

Since this intervention is non-medical and focuses on self-management and cognitive training through coaching sessions, there are no direct medical side effects associated with it.

HOBSCOTCH-PD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My doctor diagnosed me with Parkinson's Disease.

Select...

I can read and speak English and have completed at least 12 years of education.

Select...

I experience problems with my memory or thinking.

Select...

I am between 30 and 75 years old.

HOBSCOTCH-PD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-hobscotch-pd) and post-hobscotch-pd, approximately 9 weeks later. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in quality of life as measured by comparing PDQ-39 (Parkinson's Disease Questionnaire) scores pre- and post-HOBSCOTCH-PD intervention.

Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-PD intervention.

HOBSCOTCH-PD Trial Design

1Treatment groups

Experimental Treatment

Group I: PD Participant with Cognitive DysfunctionExperimental Treatment1 Intervention

Participants will receive the HOBSCOTCH-PD intervention consisting of 1:1 sessions delivered once per week including: 1 pre-HOBSCOTCH Session (on webcam or by phone) 1 educational session (on webcam) 6 HOBSCOTCH intervention sessions (webcam or phone) 1 wrap-up session (webcam or phone)

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,543,334 Total Patients Enrolled

Elaine T Kiriakopoulos, MD, MPH, MScPrincipal InvestigatorDartmouth-Hitchcock, Dartmouth College

1 Previous Clinical Trials

10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What specific characteristics or criteria make an individual more suitable for inclusion in this clinical investigation?

"To be eligible for participation in this clinical study, individuals must exhibit cognitive dysfunction and fall within the age bracket of 30 to 75 years old. The trial aims to recruit approximately five suitable candidates."

Answered by AI

What is the upper threshold for the number of individuals enrolled in this medical study?

"Yes, information on clinicaltrials.gov confirms the ongoing recruitment for this trial. The initial posting date was January 5th, 2024 with the latest update made on February 13th, 2024. Enrollment is open for five participants at a single site."

Answered by AI

Are individuals currently eligible to apply for participation in this ongoing medical study?

"Yes, records from clinicaltrials.gov indicate that this research study is presently enrolling subjects. Originally shared on January 5th, 2024, it was last revised on February 13th of the same year. The trial aims to recruit five participants at a single site."

Answered by AI

Are individuals older than 55 years being sought for enrollment in this research study?

"Eligible candidates for this scientific investigation must be between 30 and 75 years old. There are a total of 50 trials available for individuals under the age of 18, while there are 1071 studies catering to those aged over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)

Elaine T. Kiriakopoulos 2024. "HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06260228.

All > Mci